Lieh Yoon Low

Title: The Innovations of Lieh Yoon Low

Introduction

Lieh Yoon Low is an accomplished inventor based in Lexington, MA (US). He has made significant contributions to the field of genetic therapies, holding a total of 2 patents. His work focuses on developing targeted therapeutics for lysosomal storage diseases and related conditions.

Latest Patents

Lieh Yoon Low's latest patents include innovative approaches to treating lysosomal storage diseases. One patent describes "Mannose-6-phosphate bearing peptides fused to lysosomal enzymes," which involves a targeted therapeutic that combines a lysosomal enzyme with a peptide containing at least one N-linked glycosylation site. This method includes producing the therapeutic using nucleotide acids and host cells that co-express GNPT. Another patent focuses on "Lipoprotein lipase for treatment of hypertriglyceridemic-related conditions including acute pancreatitis." This invention involves a lipoprotein lipase (LPL) protein aimed at treating and preventing hypertriglyceridemia and its associated diseases, including acute pancreatitis and cardiovascular conditions.

Career Highlights

Lieh Yoon Low is currently employed at Shire Human Genetic Therapies, Inc., where he continues to advance his research and innovations. His work has the potential to significantly impact the treatment of various metabolic and endocrine disorders.

Collaborations

Lieh Yoon Low collaborates with notable colleagues, including Michael F. Concino and Bettina Strack-Logue, who contribute to his research efforts and innovations in genetic therapies.

Conclusion

Lieh Yoon Low's contributions to the field of genetic therapies through his patents and collaborations highlight his commitment to advancing medical science. His work is paving the way for new treatments that could improve the lives of many individuals suffering from lysosomal storage diseases and related conditions.